The options may be chosen on the product page View Details $109.99 BPC-157 (Spray) Regenerative ResearchThis product has multiple variants
This detailed evaluation encompasses: A comprehensive review of your medical history Lab work to assess key health markers An in-depth discussion of your health goals and contributing factors Unlike practices that rely solely on BMI calculations, we evaluate your complete health profile to create a treatment plan aligned with your unique needs
Unlike GnRH agonists that create an artificial menopause to suppress estrogen, the weight-mediated estrogen reduction through GLP-1 agonists is more physiological
Combined trial enrollment was under about 200 people, and treatment lasted weeks, not months
GHK-Cu provides dermal and collagen-supportive effects
The Cleveland Clinic notes that bariatric surgery patients are at increased risk for vitamin deficiencies and often require ongoing supplementation: Individuals Using GLP-1 Medications GLP-1 receptor agonists (such as semaglutide and tirzepatide) are commonly used for metabolic health and weight management